Vital Signs

Sign in Subscribe

Inside EU Health: Biotech Act; targeted fix of medical devices; ‘Safe Hearts Plan’ arrives

Inside EU Health

Inside EU Health: Biotech Act; targeted fix of medical devices; ‘Safe Hearts Plan’ arrives

🎄Happy Christmas! The Health Package has arrived: Biotech Act, Targeted fix of medical device and; ‘Safe Hearts Plan’

‘Safe Hearts Plan’ sets out an EU response, but critics see gaps

Cardiovascular disease

‘Safe Hearts Plan’ sets out an EU response, but critics see gaps

Critics warn that the EU’s cardiovascular disease plan lacks the strong preventive measures needed to match the scale of the problem

Europe pushes to regain ground on competitors with new Biotech Act

Europe pushes to regain ground on competitors with new Biotech Act

With the publication of the Biotech Act, the EU sets out how it intends to boost the sector’s competitive position in the face of China’s rapid rise

EU moves to fix failing medical and in vitro device rules and spur innovation

Medical devices

EU moves to fix failing medical and in vitro device rules and spur innovation

A 'targeted' revision to the MDR and IVDR promises clearer timelines, proportionate oversight and faster access to innovative technologies

Inside EU Health: Parliament pushes for bolder CMA; cardiovascular disease costs 2% EU GDP; EU backs rapid ‘test-before-treat’ diagnostic

Inside EU Health

Inside EU Health: Parliament pushes for bolder CMA; cardiovascular disease costs 2% EU GDP; EU backs rapid ‘test-before-treat’ diagnostic

Parliament pushes for a more ambitious and European Critical Medicines Act; report estimates that cardiovascular disease costs the EU 2% of GDP; and Commission backs rapid ‘Test Before Treat’ technology to reduce misuse of antibiotics

Parliament pushes for a more ambitious and European approach to Critical Medicines Act

Critical Medicines Act

Parliament pushes for a more ambitious and European approach to Critical Medicines Act

The European Parliament’s public health committee has endorsed compromise amendments to the Critical Medicines Act, setting out a more ambitious approach than member states

Cardiovascular disease is estimated to cost the EU 2% of GDP

Cardiovascular disease

Cardiovascular disease is estimated to cost the EU 2% of GDP

Ahead of tomorrow’s ‘Safe Hearts Plan’ on cardiovascular disease, the Commission released a report which shows the heavy toll on Europe’s health and its pockets

Inside EU Health: Pharma deal agreed; State of EU Health Report; WHO concludes that vaccines don’t cause autism - again

Inside EU Health

Inside EU Health: Pharma deal agreed; State of EU Health Report; WHO concludes that vaccines don’t cause autism - again

The Council and Parliament reached a deal on the Pharma Package, the latest 'State of EU Health Report' is released, and WHO confirms - once again - that vaccines do not cause autism.

EU reaches landmark pharma deal after marathon overnight talks

EU reaches landmark pharma deal after marathon overnight talks

In the early hours, the Parliament and Council managed to reach a deal on one of the EU's most complex legislative proposals, the Pharma Package

Inside EU Health: Pharma slams Commission decision to exclude Wastewater Directive from omnibus; Várhelyi reveals name of cardio plan; crunch time for Pharma Package

Inside EU Health

Inside EU Health: Pharma slams Commission decision to exclude Wastewater Directive from omnibus; Várhelyi reveals name of cardio plan; crunch time for Pharma Package

Pharma slams Commission for excluding Wastewater Directive from Environment Omnibus; Várhelyi reveals name of cardiovascular plan; Pharma trilogue continues into the night

Várhelyi reveals EU cardiovascular health plan will be called the ‘Safe Hearts Plan’

Várhelyi reveals EU cardiovascular health plan will be called the ‘Safe Hearts Plan’

The EU will call its cardiovascular strategy the ‘Safe Hearts Plan’ and will focus on prevention

Pharma sector slams Commission after Wastewater Directive excluded from Environment Omnibus

Urban Wastewater Treatment Directive

Pharma sector slams Commission after Wastewater Directive excluded from Environment Omnibus

Commission environmental simplification package leaves Wastewater Directive untouched

Inside EU Health: Rising sales of animal antimicrobials; special task force on imports; update on PABS

Inside EU Health

Inside EU Health: Rising sales of animal antimicrobials; special task force on imports; update on PABS

Rising EU sales of animal antimicrobials; special task force on food safety standards of imports; update on the Pandemic Agreement’s unfinished business

Update on Pandemic Agreement’s unfinished business

Pandemic Agreement

Update on Pandemic Agreement’s unfinished business

MEPs received an update on ongoing negotiations for the pathogen access and benefit-sharing system

Rising EU sales of animal antimicrobials raise concern

Rising EU sales of animal antimicrobials raise concern

The latest annual surveillance report from the European Medicines Agency (EMA) shows a worrying increase in antimicrobial sales for animal use across the European Union

Inside EU Health: Threat from foodborne bacteria; low-alcohol wine labelling; Serbia to join EU4Health; COVID-19 mRNA vaccines cut mortality

Inside EU Health

Inside EU Health: Threat from foodborne bacteria; low-alcohol wine labelling; Serbia to join EU4Health; COVID-19 mRNA vaccines cut mortality

Threat from foodborne bacteria; low-alcohol wine labelling; Serbia to join EU4Health programme; COVID-19 mRNA vaccines cut mortality

Listeria remains Europe's most lethal foodborne threat

Listeria remains Europe's most lethal foodborne threat

ECDC and EFSA warn over danger of Listeria and Salmonella in latest One Health report

Inside EU Health: New EU Drug Strategy; ECDC launches guide for a common response in the face of rise in avian flu; and Pharma Package flexibility could seal the deal

Inside EU Health

Inside EU Health: New EU Drug Strategy; ECDC launches guide for a common response in the face of rise in avian flu; and Pharma Package flexibility could seal the deal

EU rolls out a new drug strategy, ECDC publishes a common-response guide as avian flu surges, and fresh flexibility in the Pharma Package could clinch a deal

ECDC launches guide for a common response in the face of rise in avian flu

Avian influenza

ECDC launches guide for a common response in the face of rise in avian flu

With a surge in highly pathogenic avian influenza, the EU sets out guidance for public authorities

Inside EU Health: Council position on Critical Medicines Act; UK-US deal will removes tariffs; will the GLP-1 manufacturers step up to WHO challenge

Inside EU Health

Inside EU Health: Council position on Critical Medicines Act; UK-US deal will removes tariffs; will the GLP-1 manufacturers step up to WHO challenge

Council reaches position on Critical Medicines Act; UK-US deal will increase the cost of drugs but removes tariffs; will the GLP-1 manufacturers step up to WHO challenge

Council reaches deal on Critical Medicines Act, but level of ambition questioned

Critical Medicines Act

Council reaches deal on Critical Medicines Act, but level of ambition questioned

EU Ministers backed a joint negotiating position on the Critical Medicines Act agreement, but some consider it a missed opportunity

Inside EU Health: Maladministration finding could have consequences for health; and Commission unveils new health crisis action plan

Inside EU Health

Inside EU Health: Maladministration finding could have consequences for health; and Commission unveils new health crisis action plan

Maladministration finding could have consequences for health proposals European Ombudswoman Teresa Anjinho has found maladministration in the European Commission’s preparation of new laws, concluding it repeatedly bypassed its own Better Regulation rules. The Ombudswoman acknowledged that the Commission would sometimes have to respond urgently to different situations, but said

Maladministration finding could have consequences for health proposals

Impact assessments

Maladministration finding could have consequences for health proposals

European Ombudswoman’s findings raise questions over the transparency and accountability of health proposals

Inside EU Health: Várhelyi not ‘deaf or blind’ to pharma’s water treatment concerns; ethanol decision postponed; faster system for multinational clinical trials

Inside EU Health

Inside EU Health: Várhelyi not ‘deaf or blind’ to pharma’s water treatment concerns; ethanol decision postponed; faster system for multinational clinical trials

Várhelyi not ‘deaf or blind’ to pharma’s water treatment concerns; ethanol decision postponed; Europe launches fast-track system for multinational clinical trials

Várhelyi not ‘deaf or blind’ to pharma's concerns over Wastewater Directive

Urban Wastewater Treatment Directive

Várhelyi not ‘deaf or blind’ to pharma's concerns over Wastewater Directive

Health Commissioner says he will do ‘everything in his power’ to correct unfair burden embedded in the legislation